Repercussions of COVID-19 in hemodialysis patients: a systematic review
DOI:
https://doi.org/10.15649/cuidarte.2695Palabras clave:
SARS-CoV-2, COVID-19, Hemodialysis, Renal Insufficiency, Chronic, NursingResumen
- Previous testing for COVID-19 through an individualized approach in hemodialysis patients can be a relevant strategy
- A series of nursing actions must be carried out to promote the patients' safety, such as infection control measures, oral hygiene, aspiration of secretions, and vital signs monitoring.
- When evaluating a patient with CKD, nurses should be aware of increased values of basal cardiac troponin T or I.
- It is essential to identify early risk factors and provide timely treatment for critical cases to reduce mortality and hospitalization in this highly vulnerable group.
Introdution: The immunosuppressive state of patients with CKD increases their risk of developing poor clinical outcomes if they acquire COVID-19 infection. Objetive: To identify the scientific evidence about the repercussions of COVID-19 in hemodialysis patients. Materials and méthods: A systematic review was conducted in this study. The databases Cochrane Library, Web of Science, Science Direct, PubMed, and Virtual Health Library were searched to identify relevant studies. The methodological quality of the studies was assessed using the adapted Downs and Black checklist. The review adhered to the PRISMA guidelines. Results:A total of 16 articles were included after the screening process. All articles had a methodological quality higher than 66.8%. The most common repercussions of COVID-19 in hemodialysis patients were the increased mortality rate (75%), development of typical signs and symptoms of the disease such as fever, cough, dyspnea, and fatigue (68.75%), lymphopenia (68.75%), progression to severe acute respiratory syndrome (56.25%), need for mechanical ventilation (50%), and admission to intensive (50%). Conclusión: The hemodialysis patients are more susceptible to COVID-19 infection and, when infected by SARS-CoV-2, these patients have more adverse clinical outcomes, more serious diseases, higher mortality, and worse prognosis than the general population. The repercussions of COVID-19 in hemodialysis patients reveal a need for preventive nursing care in hemodialysis clinics.
How to cite this article: Frota Cavalcante Tahissa, Castro Jansen Raphaella, de Souza Maciel Ferreira José Erivelton, Meiru de Lima Cristefânia, Cândido Morais Huana Carolina, Pessoa Moreira Rafaella. Repercussions of COVID-19 in hemodialysis patients: a systematic review. Revista Cuidarte. 2022;13(3):e2695. http://dx.doi.org/10.15649/cuidarte.2695
Referencias
Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017-32. https://doi.org/10.1038/s41591-020-0968-3
Basile C, Combe C, Pizzarelli F, Covic A, Davenport A, Kanbay M, et al. Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres. Nephrol Dial Transplant. 2020;35(5):737-41. https://doi.org/10.1093/ndt/gfaa069
GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709-33. https://doi.org/10.1016/S0140-6736(20)30045-3
Wu J, Li J, Zhu G, Zhang Y, Bi Z, Yu Y, et al. Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. Clin J Am Soc Nephrol. 2020;15(8):1139-45. https://doi.org/10.2215/CJN.04160320
Queiroz JS, Marques PF. Nursing management in facing COVID-19 in hemodialysis services. Enferm. foco (Brasília). 2020;11(1):196-8. https://pesquisa.bvsalud.org/portal/resource/pt/biblio-1116669?lang=en
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:71. https://doi.org/10.1136/bmj.n71
Brazilian Ministry of Health. Methodological guideline: how to conduct a systematic review and meta-analysis of observational comparative studies of risk factors and prognosis. Brasília: Brazilian Ministry of Health; 2014. https://pesquisa.bvsalud.org/bvsms/resource/pt/mis-37115
Cavalcante TF, Jansen RC, Ferreira JESM, Lima CM, Morais HCC, Moreira RP. Repercussions of COVID-19 in hemodialysis patients: a systematic review. 2022. Mendeley Data: Version 1. https://doi.org/10.17632/2rywbdc3rw.1
Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377-84. https://doi.org/10.1136/jech.52.6.377
Hootman JM, Driban JB, Sitler MR, Harris KP, Cattano NM. Reliability and validity of three quality rating instruments for systematic reviews of observational studies. Res Synth Methods. 2011;2(2):110-8. https://doi.org/10.1002/jrsm.41
March JH. Oxford Centre for Evidence-based Medicine – Levels of Evidence. (March 2009) Centre For Evidence-Based Medicine. 2009.https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009
Ossareh S, Bagheri M, Abbasi M, Abolfathi S, Bohlooli A. Role of Screening for COVID-19 in Hemodialysis Wards, Results of a Single Center Study. Iran J Kidney Dis. 2020;14(5):389-98. https://pubmed.ncbi.nlm.nih.gov/32943594/
Zhang J, Cao F, Wu SK, Xiang-Heng L, Li W, Li GS, et al. Clinical characteristics of 31 hemodialysis patients with 2019 novel coronavirus: a retrospective study. Ren Fail. 2020;42(1):726-32.
https://doi.org/10.1080/0886022X.2020.1796705
Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, et al. A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection. Kidney Int. 2020;98(1):20-6. https://doi.org/10.1016/j.kint.2020.04.030
Goicoechea M, Sánchez Cámara LA, Macías N, Muñoz de Morales A, Rojas ÁG, Bascuñana A, et al. COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain. Kidney Int. 2020;98(1):27-34. https://doi.org/10.1016/j.kint.2020.04.031
Sánchez-Pérez P, González-Calero P, Poma-Saavedra FH, Orero-Calvé E, Devesa-Such R, Soldevila-Orient A, et al. Results of a healthcare organization model for COVID-19 on hemodialysis in a tertiary hospital and its subsidized centers. Nefrologia (Engl Ed). 2020;40(4):453-60. https://doi.org/10.1016/j.nefro.2020.05.006
Fouda Menye Epse Ebana HD, Halle MP, Mbele Onana C, Mbatchou BH, Luma Namme H, Ashuntantang Enow G. Epidemiologic and clinical profile, 90 days survival of incident end stage renal patient in haemodialysis during SARS-CoV2 pandemic: Experience of the General Hospital of Douala. Nephrol Ther. 2021;17(4):226-32. https://doi.org/10.1016/j.nephro.2020.12.002
Savino M, Casula A, Santhakumaran S, Pitcher D, Wong E, Magadi W, et al. Sociodemographic features and mortality of individuals on haemodialysis treatment who test positive for SARS-CoV-2: A UK Renal Registry data analysis. PLoS One. 2020;15(10):e0241263. https://doi.org/10.1371/journal.pone.0241263
Albalate M, Arribas P, Torres E, Cintra M, Alcázar R, Puerta M, et al. High prevalence of asymptomatic COVID-19 in haemodialysis: learning day by day in the first month of the COVID-19 pandemic. Nefrologia (Engl Ed). 2020;40(3):279-86. https://doi.org/10.1016/j.nefro.2020.04.005
Giaime P, Guenoun M, Pedinielli N, Narbonne H, Bergounioux JP, Solas C, et al. Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection. Nephrol Dial Transplant. 2020;35(8):1346-53. https://doi.org/10.1093/ndt/gfaa191
Ozturk S, Turgutalp K, Arici M, Odabas AR, Altiparmak MR, Aydin Z, et al. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey. Nephrol Dial Transplant. 2020;35(12):2083-95. https://doi.org/10.1093/ndt/gfaa271
Bell S, Campbell J, McDonald J, O'Neill M, Watters C, Buck K, et al. COVID-19 in patients undergoing chronic kidney replacement therapy and kidney transplant recipients in Scotland: findings and experience from the Scottish renal registry. BMC Nephrol. 2020;21(1):419. https://doi.org/10.1186/s12882-020-02061-8
Cunha TS, Gomá-Garcés E, Avello A, Pereira-García M, Mas-Fontao S, Ortiz A, et al. The Spectrum of Clinical and Serological Features of COVID-19 in Urban Hemodialysis Patients. J Clin Med. 2020;9(7):2264. https://doi.org/10.3390/jcm9072264
Keller N, Chantrel F, Krummel T, Bazin-Kara D, Faller AL, Muller C, et al. Impact of first-wave COronaVIrus disease 2019 infection in patients on haemoDIALysis in Alsace: the observational COVIDIAL study. Nephrol Dial Transplant. 2020;35(8):1338-411.https://doi.org/10.1093/ndt/gfaa170
Trivedi M, Shingada A, Shah M, Khanna U, Karnik ND, Ramachandran R. Impact of COVID-19 on maintenance haemodialysis patients: The Indian scenario. Nephrology (Carlton). 2020;25(12):929-32. https://doi.org/10.1111/nep.13760
Hendra H, Vajgel G, Antonelou M, Neradova A, Manson B, Clark SG, et al. Identifying prognostic risk factors for poor outcome following COVID-19 disease among in-centre haemodialysis patients: role of inflammation and frailty. J Nephrol. 2021;34(2):315-23. https://doi.org/10.1007/s40620-020-00960-5
Morsch CMF, Haas JS, Plotnick R, Cavalcanti TC, Cardoso PC, Pilger T, et al. Hypothermia related to continuous renal replacement therapy: incidence and associated factors. Rev Bras Ter Intensiva. 2021;33(1):111-8. https://pubmed.ncbi.nlm.nih.gov/33886860/
Almeida JFM, Chehter EZ. COVID-19 and the gastrointestinal tract: what do we already know? Einstein (Sao Paulo). 2020;18:eRW5909. https://doi.org/10.31744/einstein_journal/2020RW5909
Sharifpour M, Rangaraju S, Liu M, Alabyad D, Nahab FB, Creel-Bulos CM, et al. C-Reactive protein as a prognostic indicator in hospitalized patients with COVID-19. PLoS One. 2020;15(11):e0242400. https://doi.org/10.1371/journal.pone.0242400
Descargas
Publicado
Cómo citar
Número
Sección
Categorías
Altmetrics
Descargas
Licencia
Journal Cuidarte, scientific publication of open access, is licensed under a Creative Commons Attribution (CC BY-NC), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Any other form of use such as reproduction, transformation, public communication or distribution, for profit, requires the prior authorization of the University of Santander UDES.
The names and e-mail addresses entered in the Journal Cuidarte will be used exclusively for the purposes stated by this magazine and will not be available for any other purpose or other person.
The articles published in the Journal Cuidarte represent the criteria of their authors and do not necessarily constitute the official opinion of the University of Santander UDES.
